Baseline indoor adherence low (n=23) | Baseline indoor adherence high (n=8) | P value | All participants (n=31) | |
Age (years) | 68.3±11.2 | 72.1±4.2 | 0.357 | 69.3±9.9 |
Female gender | 39(9) | 50(4) | 0.689 | 42(13) |
BMI (kg/m2) | 30±7 | 32±8 | 0.614 | 31±7 |
Type 2 diabetes | 78(18) | 75(6) | 1.0 | 77(24) |
Diabetes duration (years)* | 19.5±15.7 | 19.5±10.2 | 0.997 | 19.5±14.5 |
LOPS, based on abnormal monofilament perception | 100(23) | 100(8) | – | 100(31) |
Amputation† | 22 (5) | 25 (2) | 1.0 | 23 (7) |
Digiti | (3) | (2) | (5) | |
Ray/Forefoot | (2) | 0 | (2) |
Data are expressed as mean±SD, or % (n). No significant differences were found between the groups baseline indoor adherence ‘low’ and ‘high’.
*Diabetes duration was available from n=27.
†Amputation up to tarsometatarsal level.
BMI, body mass index; LOPS, loss of protective sensation.